Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05777421
Other study ID # FUI/CTR/2023/5
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 1, 2023
Est. completion date July 1, 2023

Study information

Verified date March 2023
Source Foundation University Islamabad
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Knee Osteoarthritis is one of the most prevalent degenerative conditions in Pakistan. Although a variety of Physical therapy treatments have been proven to be beneficial in patients with early stages of knee Osteoarthritis. However, a few secondary impairments like Kinesiophobia which is the fear of movement have been unaddressed. Usually after conventional physical therapy, patients find immediate or short-term relief and that leads to cessation of follow up sessions. In situations like these, kinesiophobia is the greatest threat to mobility and can eventually effect quality of life by decreasing functional disability.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 24
Est. completion date July 1, 2023
Est. primary completion date June 15, 2023
Accepts healthy volunteers No
Gender All
Age group 45 Years to 65 Years
Eligibility Inclusion Criteria: - Patients with unilateral knee OA involving mediolateral compartment - Knee OA grade 2 - Aged 40-65 years - Both Male and Female - NPRS value greater than Exclusion Criteria: - Patients with history of - History of systemic disorder (e.g., rheumatoid arthritis, ankylosing spondylitis). - History of malignancy. - History of trauma. - Previous knee surgery. - Congenital musculoskeletal deformity (e.g., scoliosis, kyphosis). - Patients with history of fracture - Patients with history of Chondropatella Malacia

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Conventional Physical Therapy for Knee Osteoarthriths
Participants of Group A will receive the conventional physical therapy for Knee Osteoarthistis for a duration of 6 weeks atleast 2 times a week
Virtual Reality-Based Therapeutic Exercise regimes
Participants of Group B will receive Virtual Reality Based therapeutic exercises on the Xbox. The difficulty level of the games will progess each week. The duration of training will also also progress at treatment week progresses. Frequency: 2-3 times a week for 6 weeks. Minimum 12 sessions in total.

Locations

Country Name City State
Pakistan Foundation University College of Physical Therapy Rawalpindi Punjab

Sponsors (1)

Lead Sponsor Collaborator
Foundation University Islamabad

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Kinesiophobia Kinesiophobia will be measured using the Tampa Scale of Kinesiophobia 6 weeks
Primary Pain intensity Will be Measured using the Numeric Pain rating scale 6 weeks
Primary Functional Disability Will be measured using WOMAC Osteoarthritis Index 6 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04698265 - Efficacy of Intra-articular Injection of Human Amniotic Suspension Allograft and Platelet-rich Plasma in the Treatment of Knee Osteoarthritis. N/A